Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 98251-98300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04809506
Identification of New Biomarkers for the Prediction of Cardiovascular Events
N/ARecruiting
1,500 participants
Started: Feb 4, 2021 · Completed: Feb 3, 2034
1 condition1 sponsor1 location
NCT04719000
PErsonalized Addition of Recombinant LH in Ovarian Stimulation
PHASE4Recruiting
120 participants
Started: Feb 4, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT04053842
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy
PHASE2Active, not recruiting
45 participants
Started: Feb 4, 2021 · Completed: Sep 30, 2025
3 conditions4 sponsors1 location
NCT04453657
Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19
NAEnrolling by invitation
270 participants
Started: Feb 4, 2021 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT04746950
ALICIA (Acalabrutinib in CLL Therapy)
N/AActive, not recruiting
90 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor12 locations
NCT04685148
Maternal Mental Health Trial
PHASE1/PHASE2Recruiting
220 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2030
2 conditions3 sponsors1 location
NCT03994497
Evaluation of the Level of Expression of CD45RC on T Lymphocytes as a Predictive Biomarker of Acute Rejection After Renal Transplantation
NARecruiting
150 participants
Started: Feb 3, 2021 · Completed: Feb 2, 2026
1 condition1 sponsor1 location
NCT04666961
Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ
PHASE2Recruiting
262 participants
Started: Feb 3, 2021 · Completed: Aug 1, 2033
3 conditions1 sponsor8 locations
NCT04768426
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
PHASE2Recruiting
40 participants
Started: Feb 3, 2021 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT04375800
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)
PHASE2Recruiting
84 participants
Started: Feb 3, 2021 · Completed: Apr 11, 2034
1 condition1 sponsor24 locations
NCT04822688
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
N/AActive, not recruiting
141 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04635397
Immunomonitoring After Hematopoietic Stem Cell Transplantation
N/AActive, not recruiting
60 participants
Started: Feb 3, 2021 · Completed: Aug 18, 2026
1 condition1 sponsor1 location
NCT04624477
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
N/AActive, not recruiting
450 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2034
3 conditions10 sponsors8 locations
NCT04547439
Sleep, Diabetic Retinopathy and Melatonin
PHASE2Recruiting
42 participants
Started: Feb 3, 2021 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06324591
Observational Prospective Study to Identify Intestinal Microbial Profiles in Newly Diagnosed Crohn's Disease Patients
NAActive, not recruiting
30 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor3 locations
NCT04782947
Epidural Stimulation and Resistance Training After SCI
PHASE2/PHASE3Recruiting
20 participants
Started: Feb 3, 2021 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT04701151
NORTH-REG Dwell-Time Study
PHASE4Active, not recruiting
314 participants
Started: Feb 3, 2021 · Completed: Dec 31, 2030
1 condition12 sponsors11 locations
NCT04875286
Patient Reported Symptom Control With THC or CBD Use
N/AActive, not recruiting
200 participants
Started: Feb 3, 2021 · Completed: Feb 2, 2027
3 conditions1 sponsor2 locations
NCT04755283
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
PHASE2Active, not recruiting
1,287 participants
Started: Feb 2, 2021 · Completed: Dec 29, 2028
2 conditions3 sponsors92 locations
NCT04558593
Surveillance of Complex Renal Cysts - The SOCRATIC Study
N/ARecruiting
330 participants
Started: Feb 2, 2021 · Completed: Sep 20, 2031
1 condition1 sponsor18 locations
NCT04832620
Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas
N/ARecruiting
40 participants
Started: Feb 2, 2021 · Completed: Dec 31, 2027
6 conditions3 sponsors2 locations
NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
PHASE1Active, not recruiting
48 participants
Started: Feb 2, 2021 · Completed: Dec 31, 2024
31 conditions1 sponsor7 locations
NCT04612751
Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE1Active, not recruiting
165 participants
Started: Feb 2, 2021 · Completed: Apr 30, 2026
1 condition2 sponsors42 locations
NCT04512716
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
EARLY_PHASE1Recruiting
12 participants
Started: Feb 2, 2021 · Completed: Jan 31, 2026
11 conditions1 sponsor7 locations
NCT04739319
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression
N/ARecruiting
2,500 participants
Started: Feb 2, 2021 · Completed: Nov 30, 2040
4 conditions1 sponsor1 location
NCT05557604
Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer
PHASE2Recruiting
146 participants
Started: Feb 2, 2021 · Completed: Feb 2, 2027
1 condition1 sponsor3 locations
NCT04649359
MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
PHASE2Active, not recruiting
187 participants
Started: Feb 2, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor89 locations
NCT04619004
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
277 participants
Started: Feb 2, 2021 · Completed: Jan 30, 2026
2 conditions3 sponsors123 locations
NCT04626362
American Cranberries to Prevent UTIs in Susceptible Women
NAActive, not recruiting
55 participants
Started: Feb 2, 2021 · Completed: Aug 20, 2026
1 condition1 sponsor1 location
NCT04758715
Diet and Microbiome Longitudinal Monitoring With Food Intervention
NAActive, not recruiting
65 participants
Started: Feb 2, 2021 · Completed: Feb 28, 2030
2 conditions1 sponsor1 location
NCT04741464
Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis
NAActive, not recruiting
9 participants
Started: Feb 2, 2021 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT04743518
Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative Colitis
PHASE4Recruiting
100 participants
Started: Feb 2, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04760574
Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism
N/ARecruiting
1,200 participants
Started: Feb 2, 2021 · Completed: Nov 30, 2030
1 condition1 sponsor1 location
NCT04693936
Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis
NAActive, not recruiting
200 participants
Started: Feb 2, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT04736589
Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
PHASE3Not yet recruiting
270 participants
Started: Feb 2, 2021 · Completed: Feb 2, 2027
1 condition1 sponsor1 location
NCT04715178
Beat Childhood Cancer Specimen Banking and Data Registry
N/ARecruiting
1,000 participants
Started: Feb 2, 2021 · Completed: Jan 31, 2032
2 conditions1 sponsor15 locations
NCT04743362
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
N/ARecruiting
5,010 participants
Started: Feb 2, 2021 · Completed: Aug 2, 2031
2 conditions1 sponsor1 location
NCT03127267
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
PHASE3Recruiting
495 participants
Started: Feb 2, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor56 locations
NCT04867330
Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC
NARecruiting
46 participants
Started: Feb 1, 2021 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT04484701
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer
N/AActive, not recruiting
1,574 participants
Started: Feb 1, 2021 · Completed: Sep 30, 2028
2 conditions1 sponsor1 location
NCT04748796
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
PHASE3Recruiting
360 participants
Started: Feb 1, 2021 · Completed: Sep 30, 2027
4 conditions29 sponsors1 location
NCT05592574
IL17 Rate and Spondyloarthritis
N/ARecruiting
50 participants
Started: Feb 1, 2021 · Completed: Jan 31, 2041
1 condition1 sponsor1 location
NCT04230447
Establishment of a Cohort of Patients With Sepsis-associated Encephalopathy (SAE)
N/ARecruiting
3,000 participants
Started: Feb 1, 2021 · Completed: Jan 14, 2030
1 condition1 sponsor1 location
NCT04186286
Crossover Study of Propranolol vs Ivabradine in POTS
PHASE2Recruiting
20 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04879563
Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project
PHASE2Active, not recruiting
500 participants
Started: Feb 1, 2021 · Completed: Aug 30, 2025
5 conditions15 sponsors5 locations
NCT04883450
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer
N/AActive, not recruiting
126 participants
Started: Feb 1, 2021 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT04411823
Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
NARecruiting
200 participants
Started: Feb 1, 2021 · Completed: Oct 31, 2028
3 conditions1 sponsor2 locations
NCT04733820
Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery
PHASE3Recruiting
340 participants
Started: Feb 1, 2021 · Completed: Feb 1, 2028
2 conditions7 sponsors1 location
NCT04775108
First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve System
NARecruiting
40 participants
Started: Feb 1, 2021 · Completed: Dec 31, 2029
1 condition1 sponsor10 locations
NCT04814082
Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee Arthroplasty
NARecruiting
100 participants
Started: Feb 1, 2021 · Completed: Jul 1, 2030
8 conditions3 sponsors1 location